Logo image of ZYME

ZYMEWORKS INC (ZYME) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:ZYME - US98985Y1082 - Common Stock

23.55 USD
-0.4 (-1.67%)
Last: 1/22/2026, 8:12:59 PM
23.17 USD
-0.38 (-1.61%)
After Hours: 1/22/2026, 8:12:59 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ZYME revenue by date.ZYME revenue by date.
412.5M
1,444.94%
76.012M
-81.57%
76.304M
0.38%
125.28M
64.19%
240.51M
91.98%
189.2M
-21.33%
236.71M
25.11%
349.48M
47.64%
461M
31.91%
598.07M
29.73%
789.77M
32.05%
744.37M
-5.75%
EBITDA
YoY % growth
ZYME ebitda by date.ZYME ebitda by date.
137.7M
165.85%
-127.889M
-192.88%
-111.139M
13.10%
-82.255M
25.99%
38.166M
146.40%
106.39M
178.76%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ZYME ebit by date.ZYME ebit by date.
130.5M
160.53%
-138.053M
-205.79%
-119.823M
13.21%
-82.119M
31.47%
17.096M
120.82%
-11.853M
-169.33%
8.575M
172.34%
58.503M
582.25%
103.93M
77.65%
167.6M
61.26%
270.8M
61.58%
267.37M
-1.27%
Operating Margin
ZYME operating margin by date.ZYME operating margin by date.
31.64%-181.62%-157.03%-65.55%7.11%-6.27%3.62%16.74%22.54%28.02%34.29%35.92%
EPS
YoY % growth
ZYME eps by date.ZYME eps by date.
1.93
146.96%
-1.73
-189.64%
-1.39
19.65%
-1.01
27.60%
-0.43
57.28%
-0.53
-22.89%
0.25
146.81%
0.43
74.23%
0.85
98.22%
1.45
69.85%
2.24
54.19%
2.04
-8.66%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.43
-38.76%
-0.10
67.53%
-0.36
-1,292.72%
-0.36
-38.64%
0.21
148.56%
-0.32
-228.80%
0.39
210.32%
-0.28
22.18%
-0.26
-225.98%
-0.24
24.20%
-0.23
-157.11%
-0.20
29.45%
Revenue
Q2Q % growth
13.848M
-55.37%
27.149M
0.14%
28.388M
-41.74%
22.464M
-18.65%
126.13M
810.82%
N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
-11.672M
13.75%
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-38.169M
-71.80%
-29.495M
-15.16%
-22.803M
-3,283.20%
-23.004M
-4.04%
113.42M
397.15%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.26
33.33%
-0.330.0720.62%
Q2 2025
Q2Q % growth
0.03
111.11%
-0.500.53105.95%
Q1 2025
Q2Q % growth
-0.30
28.57%
-0.420.1228.01%
Q4 2024
Q2Q % growth
-0.31
-55.00%
-0.10-0.21-206.99%
Q3 2024
Q2Q % growth
-0.39
4.88%
-0.400.013.34%
Q2 2024
Q2Q % growth
-0.27
64.47%
-0.320.0516.42%
Q1 2024
Q2Q % growth
-0.42
-16.67%
-0.30-0.12-41.99%
Q4 2023
Q2Q % growth
-0.20
-104.30%
-0.440.2454.79%
Q3 2023
Q2Q % growth
-0.41
43.06%
-0.480.0714.36%
Q2 2023
Q2Q % growth
-0.76
21.65%
-0.48-0.28-58.39%
Q1 2023
Q2Q % growth
-0.36
65.05%
-0.550.1934.22%
Q4 2022
Q2Q % growth
4.65
711.84%
4.94-0.29-5.81%
Q3 2022
Q2Q % growth
-0.72
38.46%
-0.940.2223.34%
Q2 2022
Q2Q % growth
-0.97
25.95%
-0.980.011.26%
Q1 2022
Q2Q % growth
-1.03
-18.39%
-1.700.6739.39%
Q4 2021
Q2Q % growth
-0.76
-2.70%
-1.160.4034.70%
Q3 2021
Q2Q % growth
-1.17
18.18%
-1.190.021.69%
Q2 2021
Q2Q % growth
-1.31
-70.13%
-1.07-0.24-22.15%
Q1 2021
Q2Q % growth
-0.87
-35.94%
-1.050.1817.46%
Q4 2020
Q2Q % growth
-0.74 -1.250.5140.70%
Q3 2020
Q2Q % growth
-1.43 -0.93-0.50-54.53%
Q2 2020
Q2Q % growth
-0.77 -0.880.1112.05%
Q1 2020
Q2Q % growth
-0.64 -1.090.4541.27%
ZYME Yearly EPS VS EstimatesZYME Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
27.614M
72.59%
30.049M-2.435M-8.10%
Q2 2025
Q2Q % growth
48.726M
153.21%
19.763M28.963M146.55%
Q1 2025
Q2Q % growth
27.11M
170.29%
21.066M6.044M28.69%
Q4 2024
Q2Q % growth
31.031M
83.33%
46.104M-15.073M-32.69%
Q3 2024
Q2Q % growth
16M
-3.07%
15.609M391K2.50%
Q2 2024
Q2Q % growth
19.243M
174.82%
20.494M-1.251M-6.10%
Q1 2024
Q2Q % growth
10.03M
-71.81%
17.78M-7.75M-43.59%
Q4 2023
Q2Q % growth
16.926M
-95.79%
15.758M1.168M7.41%
Q3 2023
Q2Q % growth
16.506M
534.85%
10.373M6.133M59.12%
Q2 2023
Q2Q % growth
7.002M
29.67%
12.607M-5.605M-44.46%
Q1 2023
Q2Q % growth
35.578M
1,772.53%
19.916M15.662M78.64%
Q4 2022
Q2Q % growth
402.5M
1,922.61%
378.73M23.77M6.28%
Q3 2022
Q2Q % growth
2.6M
-40.91%
4.047M-1.447M-35.75%
Q2 2022
Q2Q % growth
5.4M
200.00%
6.197M-797K-12.86%
Q1 2022
Q2Q % growth
1.9M
216.67%
3.536M-1.636M-46.27%
Q4 2021
Q2Q % growth
19.9M
26.75%
9.315M10.585M113.63%
Q3 2021
Q2Q % growth
4.4M
69.23%
7.487M-3.087M-41.23%
Q2 2021
Q2Q % growth
1.8M
-85.48%
7.24M-5.44M-75.14%
Q1 2021
Q2Q % growth
600K
-92.77%
7.257M-6.657M-91.73%
Q4 2020
Q2Q % growth
15.7M 10.506M5.194M49.44%
Q3 2020
Q2Q % growth
2.6M 12.978M-10.378M-79.97%
Q2 2020
Q2Q % growth
12.4M 8.28M4.12M49.76%
Q1 2020
Q2Q % growth
8.3M 7.909M391K4.94%
ZYME Yearly Revenue VS EstimatesZYME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.49% -106.4% 0.67% -14.72%
Revenue-13.71% -69.83% 0.38% -20.97%